Humedix Co., Ltd.

KOSDAQ 200670.KQ

Humedix Co., Ltd. Market Capitalization on January 14, 2025: USD 265.40 M

Humedix Co., Ltd. Market Capitalization is USD 265.40 M on January 14, 2025, a 6.46% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Humedix Co., Ltd. 52-week high Market Capitalization is USD 324.12 M on December 23, 2024, which is 22.12% above the current Market Capitalization.
Humedix Co., Ltd. 52-week low Market Capitalization is USD 186.21 M on November 14, 2024, which is -29.84% below the current Market Capitalization.
Humedix Co., Ltd. average Market Capitalization for the last 52 weeks is USD 247.09 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

KOSDAQ: 200670.KQ

Humedix Co., Ltd.

CEO	Jin-hwan Kim
IPO Date	Dec. 26, 2014
Location	South Korea
Headquarters	603, 268, Hagui-ro
Employees	226
Sector	Health Care
Industries Pharmaceuticals Cosmetics Drugstores & Retail Pharmacies

Description

Humedix Co., Ltd., a healthcare company, researches, develops, manufactures, and sells various pharmaceutical products in South Korea. It offers over-the-counter drugs, prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic products, and functional synthetic materials, as well as health functional foods. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. The company was founded in 2002 and is headquartered in Anyang-si, South Korea.

Key trends

Past 5 years